| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rivastigmine | FAERS: 3 | US FAERS | |
| 2 | Dabigatran | FAERS: 2 | US FAERS | |
| 3 | Metronidazole | FAERS: 2 | US FAERS | |
| 4 | Acetaminophen | FAERS: 1 | US FAERS | |
| 5 | Fentanyl | FAERS: 1 | US FAERS | |
| 6 | Ferric Oxide, Saccharated | FAERS: 1 | US FAERS | |
| 7 | Loratadine | FAERS: 1 | US FAERS | |
| 8 | Midazolam | FAERS: 1 | US FAERS | |
| 9 | Oxaydo | FAERS: 1 | US FAERS | |
| 10 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 11 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 12 | iodixanol | FAERS: 1 | US FAERS | |
| 13 | ledipasvir, sofosbuvir drug combination | FAERS: 1 | US FAERS | |
| 14 | eslicarbazepine | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.